Viking Therapeutics (NASDAQ: VKTX), a biotech that has shot to prominence thanks to a weight-loss drug it is developing, was ...

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 ...

GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock ...

Novo Nordisk said the Food and Drug Administration accepted its submission of a new drug application for a Wegovy pill to treat obesity amid a tense race to get an oral weight-loss medication on the ...

Analysts were rushing to reiterate their conviction in the stock following Thursday’s blow to Zepbound and Lilly shares.

The event hosted by the Worth Avenue Association begins at 1 p.m. May 3 and wraps up with a fashion show and hat contest in Via Mizner at 5 p.m.

Vice President Vance appeared briefly at a May 1 $1 million-per-person fundraiser hosted at Worth Avenue's Le Bilboquet restaurant.